0001372514-23-000029.txt : 20230307 0001372514-23-000029.hdr.sgml : 20230307 20230307201328 ACCESSION NUMBER: 0001372514-23-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHANEY PAUL G CENTRAL INDEX KEY: 0001277477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 23714560 MAIL ADDRESS: STREET 1: 3 TIMES SQUARE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 781-788-8869 MAIL ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 FORMER COMPANY: FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060811 4 1 wf-form4_167823799654732.xml FORM 4 X0306 4 2023-03-03 0 0001372514 KIORA PHARMACEUTICALS INC KPRX 0001277477 CHANEY PAUL G 332 ENCINITAS BLVD., SUITE 102 ENCINITAS CA 92024 1 0 0 0 Stock Option (right to buy) 3.83 2023-03-03 4 A 0 8000 0 A 2033-03-03 Common Stock 8000.0 8000 D The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. /s/ Robert A. Petitt, Attorney-in-Fact 2023-03-08